Currently, as announced earlier this year, the National Research Council is negotiating a manufacturing agreement with the U.S. biopharmaceutical company Novavax, to produce their vaccine candidate at the facility.
Director General, Strategy and Performance, National Research Council of Canada
Currently, as announced earlier this year, the National Research Council is negotiating a manufacturing agreement with the U.S. biopharmaceutical company Novavax, to produce their vaccine candidate at the facility.
See context to find out what was said next.